Chiu H-Y, Wang T-S, Chen P-H, Hsu S-H, Tsai Y-C, Tsai T-F. Psoriasis in Taiwan: from epidemiology to new treatments. Dermatologica Sin. 2018;36:115–23.

Google Scholar 

Tsai T-F, Wang T-S, Hung S-T, Tsai PI-C, Schenkel B, Zhang M, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci. 2011;63:40–6.

PubMed  Google Scholar 

Ohata C, Ishii N, Koga H, Fukuda S, Tateishi C, Tsuruta D, et al. Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: a series of 145 cases. J Am Acad Dermatol. 2015;73:50–5. https://doi.org/10.1016/j.jaad.2015.03.016.

Article  PubMed  Google Scholar 

Takagi Y, Sawada S, Yamauchi M, Amagai M, Niimura M. Coexistence of psoriasis and linear IgA bullous dermatosis. Br J Dermatol. 2000;142:513–6.

CAS  PubMed  Google Scholar 

Kabashima R, Hino R, Bito T, Kabashima K, Nakamura M, Oyama B, et al. Epidermolysis bullosa acquisita associated with psoriasis. Acta Derm Venereol. 2010;90:314–6.

PubMed  Google Scholar 

Kridin K, Ahmed AR. Anti-p200 pemphigoid: a systematic review. Front Immunol. 2019;10:2466.

CAS  PubMed  PubMed Central  Google Scholar 

Phan K, Goyal S, Murrell DF. Association between bullous pemphigoid and psoriasis: systematic review and meta-analysis of case-control studies. Australas J Dermatol. 2019;60:23–8.

PubMed  Google Scholar 

Kobayashi TT, Elston DM, Libow LF, David-Bajar K. A case of bullous pemphigoid limited to psoriatic plaques. Cutis. 2002;70:283–7.

PubMed  Google Scholar 

Ständer S, Schmidt E, Zillikens D, Thaçi D, Ludwig RJ, Kridin K. Patients with bullous pemphigoid and comorbid psoriasis present with less blisters and lower serum levels of anti-BP180 autoantibodies. J Eur Acad Dermatol Venereol. 2021;35:981–7.

PubMed  Google Scholar 

Wilczek A, Sticherling M. Concomitant psoriasis and bullous pemphigoid: coincidence or pathogenic relationship? Int J Dermatol. 2006;45:1353–7.

PubMed  Google Scholar 

Loget J, Plée J, Antonicelli F, Bernard P. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis. J Eur Acad Dermatol Venereol. 2017;31:e228–30.

CAS  PubMed  Google Scholar 

Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020;82:1445–86. https://doi.org/10.1016/j.jaad.2020.02.044.

CAS  Article  PubMed  Google Scholar 

Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029–72. https://doi.org/10.1016/j.jaad.2018.11.057.

Article  PubMed  Google Scholar 

Feliciani C, Joly P, Jonkman MF, Zambruno G, Zillikens D, Ioannides D, et al. Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology. Br J Dermatol. 2015;172:867–77.

CAS  PubMed  Google Scholar 

George PM. Bullous pemphigoid possibly induced by psoralen plus ultraviolet A therapy. Photodermatol Photoimmunol Photomed. 1996;11:2007–9.

Google Scholar 

Kluk J, Goulding JMR, Bhat J, Finch TM. Drug-induced bullous pemphigoid: cases triggered by intravenous iodine and etanercept. Clin Exp Dermatol. 2011;36:871–3.

CAS  PubMed  Google Scholar 

Patients S, Joly P, Roujeau J-C, Benichou J, Picard C, Dreno B, et al. Comparison of oral and topical coricosterids in patients with bullous emphigoid a comparison of oral and topical corticosteroids in patients. N Engl J Med. 2002;346:321–7.

Google Scholar 

Samarasekera EJ, Sawyer L, Wonderling D, Tucker R, Smith CH. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168:954–67.

CAS  PubMed  Google Scholar 

Tukaj S, Grüner D, Tukaj C, Zillikens D, Kasperkiewicz M. Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid. J Eur Acad Dermatol Venereol. 2016;30:288–92.

CAS  PubMed  Google Scholar 

Tukaj S. Vitamin D in autoimmune bullous disease. Acta Biochim Pol. 2020;67:1–5.

CAS  PubMed  Google Scholar 

Maki N, Demitsu T, Umemoto N, Nagashima K, Nakamura T, Kakurai M, et al. Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia. J Dermatol. 2016;43:571–4.

CAS  PubMed  Google Scholar 

Si X, Ge L, Xin H, Cao W, Sun X, Li W. Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin. Diagn Pathol. 2014;9:2–5.

Google Scholar 

Barnadas MA, Gilaberte M, Pujol R, Agustí M, Gelpí C, Alomar A. Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: study by ELISA test. Int J Dermatol. 2006;45:1089–92.

PubMed  Google Scholar 

Querol-Cisneros E, Moreno-Artero E, Rodríguez-Garijo N, Tomás-Velázquez A, Querol I, Ishii N, et al. Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab. J Ger Soc Dermatol. 2021;19:265–7.

Google Scholar 

Nakayama C, Fujita Y, Watanabe M, Shimizu H. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab. J Dermatol. 2015;42:996–8.

CAS  PubMed  Google Scholar 

Yamauchi PS, Lowe NJ, Gindi V. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006;54:121–2.

Google Scholar 

Grunwald MH, David M, Feuerman EJ. Coexistence of psoriasis vulgaris and bullous diseases. J Am Acad Dermatol. 1985;13:224–8.

CAS  PubMed  Google Scholar 

Cusano F, Iannazzone SS, Riccio G, Piccirillo F. Coexisting bullous pemphigoid and psoriasis successfully treated with etanercept. Eur J Dermatol. 2010;20:520.

PubMed  Google Scholar 

Monnier-Murina K, Du Thanh A, Merlet-Albran S, Guillot B, Dereure O. Bullous pemphigoid occurring during efalizumab treatment for psoriasis: a paradoxical auto-immune reaction? Dermatology. 2009;219:89–90.

PubMed  Google Scholar 

Lazarczyk M, Wozniak K, Ishii N, Gorkiewicz-Petkov A, Hashimoto T, Schwarz R, et al. Coexistence of psoriasis and pemphigoid—only a coincidence? Int J Mol Med. 2006;18:619–23.

CAS  PubMed  Google Scholar 

Marin M, Alzueta N, Castresana M, Gascón A, Pío M. Bullous pemphigoid induced by ustekinumab: a case report. Eur J Hosp Pharm. 2021;28:47–9.

PubMed  Google Scholar 

Kamata M, Asano Y, Shida R, Maeda N, Yoshizaki A, Miyagaki T, et al. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid. J Dermatol. 2019;46:e216–7.

PubMed  Google Scholar 

Burch J, Sebaratnam D. How do prednisolone/prednisone, alone or in combination with other interventions affect outcomes in people with bullous pemphigoid? Cochrane Clin Ans. 2014. https://doi.org/10.1002/cca.506.

Article  Google Scholar 

Kjellman P, Eriksson H, Berg P. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol. 2008;144:612–6.

CAS  PubMed  Google Scholar 

Vargas P, Giacaman P, Fernández J, Morales C. Bullous pemphigoid associated with psoriasis: a good response to methotrexate. An Bras Dermatol. 2019;94:224–6.

PubMed  PubMed Central  Google Scholar 

Gunay U, Gunduz K, Türel Ermertcan A, Kandiloǧlu AR. Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate. Cutan Ocul Toxicol. 2013;32:168–9.

PubMed  Google Scholar 

Lesniewska A, Kalińska-Bienias A, Kowalewski C, Schwartz R, Wozniak K. Development of bullous pemphigoid in a patient with psoriasis and metabolic syndrome. Cutis. 2016;98:e19-23.

PubMed  Google Scholar 

Suwarsa O, Herlina L, Sutedja E, Dharmadji HP, Hindritiani R, Gunawan H. Concurrence of bullous pemphigoid and psoriasis: a case report. Serbian J Dermatol Venereol. 2018;10:124–8.

Google Scholar 

Svigos K, Fried L, Yin L, Brinster N, Lo Sicco K, Adotama P. A new eruption of bullous pemphigoid within psoriatic plaques following cyclosporine withdrawal. JAAD Case Rep. 2021;8:23–5. https://doi.org/10.1016/j.jdcr.2020.12.001.

Article  PubMed  Google Scholar 

Wang TS, Tsai TF. Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low dose methotrexate. Acta Derm Venereol. 2014;94:108–9.

PubMed  Google Scholar 

Rao R, Yunis F, Chandrashekar B, Gupta A, Handettu S. Coexistence of psoriasis with bullous pemphigoid. Indian Dermatol Online J. 2012;3:119.

CAS  PubMed  PubMed Central  Google Scholar 

Onsun N, Sallahoglu K, Dizman D, Su Ö, Tosuner Z. Bullous pemphigoid during ustekinumab therapy in a psoriatic patient. Eur J Dermatol. 2017;27:81–2.

PubMed  Google Scholar 

Imanishi A, Tateishi C, Imanishi H, Sowa-Osako J, Koga H, Tsuruta D, et al. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: Successful disease control with cyclosporin. J Dermatol. 2015;42:394–7.

PubMed  Google Scholar 

Boixeda JP, Soria C, Medina S, Ledo A. Bullous pemphigoid and psoriasis: treatment with cyclosporine. J Am Acad Dermatol. 1991;24:152.

CAS  PubMed  Google Scholar 

Verma P, Verma KK, Khanna N, Gupta S, Bhari N. Effectiveness of weekly azathioprine pulse in the treatment of chronic plaque psoriasis: an open-label study. Clin Exp Dermatol. 2016;41:717–22.

CAS  PubMed  Google Scholar 

Burton JL, Harman RR, Peachey RD, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. Br Med J. 1978;2:1190–1.

CAS  PubMed  PubMed Central  Google Scholar 

Primka EJ, Camisa C. Psoriasis and bullous pemphigoid treated with azathioprine. J Am Acad Dermatol. 1998;39:121–3.

PubMed  Google Scholar 

Plée J, Le Jan S, Giustiniani J, Barbe C, Joly P, Bedane C, et al. Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome. Sci Rep. 2015;5:18001.